HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exosomes derived from pioglitazone-pretreated MSCs accelerate diabetic wound healing through enhancing angiogenesis.

AbstractBACKGROUND:
Enhanced angiogenesis can promote diabetic wound healing. Mesenchymal stem cells (MSCs)-derived exosomes, which are cell-free therapeutics, are promising candidates for the treatment of diabetic wound healing. The present study aimed to investigate the effect of exosomes derived from MSCs pretreated with pioglitazone (PGZ-Exos) on diabetic wound healing.
RESULTS:
We isolated PGZ-Exos from the supernatants of pioglitazone-treated BMSCs and found that PGZ-Exos significantly promote the cell viability and proliferation of Human Umbilical Vein Vascular Endothelial Cells (HUVECs) injured by high glucose (HG). PGZ-Exos enhanced the biological functions of HUVECs, including migration, tube formation, wound repair and VEGF expression in vitro. In addition, PGZ-Exos promoted the protein expression of p-AKT, p-PI3K and p-eNOS and suppressed that of PTEN. LY294002 inhibited the biological function of HUVECs through inhibition of the PI3K/AKT/eNOS pathway. In vivo modeling in diabetic rat wounds showed that pioglitazone pretreatment enhanced the therapeutic efficacy of MSCs-derived exosomes and accelerated diabetic wound healing via enhanced angiogenesis. In addition, PGZ-Exos promoted collagen deposition, ECM remodeling and VEGF and CD31 expression, indicating adequate angiogenesis in diabetic wound healing.
CONCLUSIONS:
PGZ-Exos accelerated diabetic wound healing by promoting the angiogenic function of HUVECs through activation of the PI3K/AKT/eNOS pathway. This offers a promising novel cell-free therapy for treating diabetic wound healing.
AuthorsYiqiang Hu, Ranyang Tao, Lang Chen, Yuan Xiong, Hang Xue, Liangcong Hu, Chenchen Yan, Xudong Xie, Ze Lin, Adriana C Panayi, Bobin Mi, Guohui Liu
JournalJournal of nanobiotechnology (J Nanobiotechnology) Vol. 19 Issue 1 Pg. 150 (May 21 2021) ISSN: 1477-3155 [Electronic] England
PMID34020670 (Publication Type: Journal Article)
Chemical References
  • Angiogenesis Inducing Agents
  • Collagen
  • Pioglitazone
Topics
  • Angiogenesis Inducing Agents (pharmacology)
  • Animals
  • Cell Movement (drug effects)
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Collagen (metabolism)
  • Diabetes Mellitus (metabolism)
  • Diabetes Mellitus, Experimental
  • Exosomes (metabolism)
  • Human Umbilical Vein Endothelial Cells (drug effects)
  • Humans
  • Male
  • Mesenchymal Stem Cells (metabolism)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Pioglitazone (metabolism, pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Skin (drug effects)
  • Wound Healing (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: